Tags: Drug.

Volasertib (also known as BI 6727) is a small molecule inhibitor of the PLK1 (polo-like kinase 1) protein being developed by Boehringer Ingelheim for use as an anti-cancer agent. Volasertib is the second in a novel class of drugs called dihydropteridinone derivatives.

Volasertib.svg
CAS number
755038-65-4
FDA UNII code
6EM57086EA
IUPAC name
N-((1S4S)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5678-tetrahydropteridin-2-yl)amino)-3-methoxybenzamide

Loading...

This page contains content from the copyrighted Wikipedia article "Volasertib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.